Richard Wheeler
Family Medicine · Nashville, GANPI 1619954112
Payments from drug & device makers
Across 143 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$702
- GSK$303
- Dexcom, Inc.$159
- Lilly USA, LLC$152
- Boehringer Ingelheim$148
- AstraZeneca$109
- plus $788 from 20 others
What the payments were for
- Food & beverage$2,360100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $702 |
| GSK | 16 | $303 |
| Dexcom, Inc. | 9 | $159 |
| Lilly USA, LLC | 9 | $152 |
| Boehringer Ingelheim | 8 | $148 |
| AstraZeneca | 7 | $109 |
| Amgen | 6 | $99 |
| Novo Nordisk | 5 | $94 |
| Bayer | 5 | $93 |
| Idorsia Pharmaceuticals US Inc | 5 | $85 |
| Pfizer | 5 | $74 |
| Johnson & Johnson | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $48 |
| Merck | 3 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $30 |
| Novartis | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Biogen | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Kvk-tech, Inc. | 1 | $6 |
How this compares
$2,360 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 293 | $195,790 |
| MounjaroTirzepatide | 83 | $123,660 |
| OzempicSemaglutide | 102 | $101,047 |
| JardianceEmpagliflozin | 113 | $100,466 |
| IngrezzaValbenazine Tosylate | 11 | $92,666 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 106 | $87,830 |
| LinzessLinaclotide | 55 | $50,028 |
| JanuviaSitagliptin Phosphate | 41 | $42,755 |
| MyrbetriqMirabegron | 62 | $38,051 |
| RybelsusSemaglutide | 19 | $36,420 |
| TradjentaLinagliptin | 42 | $36,080 |
| FarxigaDapagliflozin Propanediol | 33 | $33,821 |
| TrulicityDulaglutide | 30 | $33,177 |
| XareltoRivaroxaban | 43 | $31,627 |
| VraylarCariprazine Hcl | 18 | $27,399 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Synjardy, Stiolto Respimat | $148 | $196,644238 claims |
| PfizerEliquis | $74 | $195,790293 claims |
| Lilly USA, LLCMounjaro, Trulicity | $152 | $156,837113 claims |
| Novo NordiskOzempic, Rybelsus | $94 | $137,467121 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $303 | $129,727173 claims |
| MerckJanuvia, Janumet, Janumet Xr, Belsomra | $37 | $83,66394 claims |
| AbbVieLinzess, Vraylar | $702 | $77,42873 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $109 | $58,16171 claims |
| Astellas Pharma US IncMyrbetriq | $20 | $38,05162 claims |
| Johnson & JohnsonXarelto | $55 | $31,62743 claims |
| NovartisEntresto, Exelon | $23 | $16,76022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Nashville
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.